(Q28395304)

2

0 references

Satoko Kishimoto

3

0 references

Mitsuyuki Kawakami

4

0 references

Satoshi Suzuki

5

0 references

Takemi Matsui

6

0 references

Masayuki Ishihara

International Journal of Nanomedicine

7

0 references

language of work or name

English

0 references

publication date

7 April 2010

0 references

published in

0 references

volume

5

0 references

page(s)

147-55

0 references

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

start time

1 March 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Skin as a route of exposure and sensitization in chronic beryllium disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865009

Human stem cell factor (SCF) is a heparin-binding cytokine

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865009

Particle size of liposomes influences dermal delivery of substances into skin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865009

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865009

Structural features in heparin that interact with VEGF165 and modulate its biological activity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865009

Heparan sulfate: a piece of information

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865009

More to "heparin" than anticoagulation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865009

Controlled release of FGF-2 using fragmin/protamine microparticles and effect on neovascularization

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865009

Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man

27 November 2018

1 reference

12 December 2020

The interaction of chitosan with fibroblast growth factor-2 and its protection from inactivation

1 reference

12 December 2020

Controlled release of fibroblast growth factor-2 from an injectable 6-O-desulfated heparin hydrogel and subsequent effect on in vivo vascularization

1 reference

12 December 2020

Effect of controlled release of fibroblast growth factor-2 from chitosan/fucoidan micro complex-hydrogel on in vitro and in vivo vascularization

1 reference

12 December 2020

Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel

1 reference

12 December 2020

Heparin protects basic and acidic FGF from inactivation

1 reference

12 December 2020

In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantation

1 reference

12 December 2020

Identifiers

DOI

10.2147/IJN.S8692

1 reference

release_nfee5xxaknfx3oaojbjzw2yply

1578893

Fatcat ID

0 references

1578893

1 reference

1 reference

1 reference